Sterling Capital Management’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.13K Sell
180
-147
-45% -$3.2K ﹤0.01% 2600
2026
Q1
$5.68K Sell
327
-13
-4% -$246 ﹤0.01% 2669
2025
Q4
$6.41K Buy
340
+208
+158% +$3.48K ﹤0.01% 2807
2025
Q3
$1.92K Hold
132
﹤0.01% 2985
2025
Q2
$2.58K Sell
132
-570
-81% -$10.1K ﹤0.01% 2847
2025
Q1
$12.5K Sell
702
-570
-45% -$12.3K ﹤0.01% 1795
2024
Q4
$27.2K Buy
1,272
+1,126
+771% +$27.4K ﹤0.01% 1783
2024
Q3
$4.56K Buy
+146
New +$3.63K ﹤0.01% 1802
2017
Q2
Sell
-11,856
Closed -$17K 942
2017
Q1
$17K Hold
11,856
﹤0.01% 949
2016
Q4
$32K Buy
+11,856
New +$41.1K ﹤0.01% 948

Other funds holding CDNA

Sterling Capital Management's CDNA Position: Q2 2026 in Review

Sterling Capital Management reduced its CareDx (CDNA) stake by 45% in Q2 2026, selling an estimated $3.2K and leaving 180 shares worth $5.13K. The position accounts for ﹤0.01% of the portfolio, ranked #2600.

Sterling Capital Management first reported a position in CDNA in Q4 2016 and has held it in 10 quarters since. The position peaked at $32K in Q4 2016. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

  • Sterling Capital Management held 180 shares of CareDx worth $5.13K as of Q2 2026.
  • Sterling Capital Management sold 147 CareDx shares in Q2 2026, an estimated $3.2K.
  • CareDx made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #2600 holding.
  • Sterling Capital Management first reported a position in CareDx in Q4 2016 and has held it in 10 quarters since.
  • Sterling Capital Management's CareDx position peaked at $32K in Q4 2016.
  • 227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.